NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,716.07 mln
Float511 mln
Earnings Date11/11/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-4.98
Highly reliable
1-Year Forecast
7.22
Transformational upside
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.07
Debt-free
Pre-Tax Margin
-970%
Severely loss-making
Business Description
Recursion Pharmaceuticals is a US and UK-based drug discovery company that combines biology, chemistry, automation, and data science to find new treatments more efficiently than traditional methods allow. Founded in 2013 and headquartered in Salt Lake City, Utah, the company is currently running multiple clinical trials targeting cancers, rare genetic conditions, and blood disorders. Recursion works alongside major pharmaceutical partners including Roche, Sanofi, Bayer, and Takeda to advance its pipeline of experimental medicines.
